Diabetes is one of the leading causes of blindness among working age adults
The early stages of diabetic retinopathy do not manifest recognizable eye disease symptoms for the patient. While almost 80% of all diabetics will develop some form of retinopathy in their lifetime, current technology has only allowed eye doctors to diagnose retinopathy after it appears clinically.
Optometry plays a vital role in the detection and management of retinopathy in diabetic patients. Most major medical insurance plans require a yearly dilated fundus evaluation for diabetic patients. The earliest detection, treatment and proper follow-up care can protect against vision loss.
Our eye doctors are proud to offer new services in our eye care clinic, the Diopsys Diabetic Screening Exam for diabetic patients with no clinically observed retinopathy, and the Flicker ERG for patients with clinical manifestations of retinopathy. Electroretinography (ERG) testing provides objective and functional information which can often precede clinically observable structural changes. The test gives your eye doctor a way to quickly assess the functional state of the entire retina to find out if there are photoreceptor cells unduly stressed by diabetic ischemia. The ERG allows your optometrist to detect the earliest sign of retinal dysfunction.
This eye care test is fast, easy and non-invasive. It uses flashes of light to stimulate the outer layer of the retina, including photoreceptors and bipolar cells, to evaluate the functional integrity of the overall retina.
The Chromatic Vision Screener ERG exam is designed to test pre-diabetic retinopathy patients to detect early retinal stress. This allows us to communicate with their attending physician that the patient is on the path for diabetic complications and needs tighter control, or that they are well controlled.
The Fliker ERG is performed on patients with existing retinopathy. This test gives us a clinical measure of the current level of stress on the retina, and allow us to monitor further regression or improvement. This test can be filed to major medical insurance. The results of the test are also communicated to the patients diabetic physician to help guide the need for tighter control.
Our eye doctors are excited to have this cutting edge technology in our practice to help in the fight to prevent blindness for diabetic eye disease.
– Dr. Ken Moultrie